Financials
Financial year 2025
ONCOLOGIX from Elsene, company number BE1027890093, closed financial year 2025 with a result of € 29,775 after tax. For that financial year ONCOLOGIX recorded a gross margin of € 37,479 and equity of € 29,776. The company is profitable. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 28, 2026.
€ 29,776
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 29,775
Profit after tax over the fiscal year.
€ 11,941
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 29,775.
People and assets in 2025
≈ 1
No payroll staff. One director, so that person most likely runs the business.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 10,625
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
What happened to ONCOLOGIX?
What happened at ONCOLOGIX in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 29,775. filed late Source: NBB ↗
- New establishment in Elsene. KBO
- Start of the company according to the CBE. KBO
In short
Paid € 7,532 in corporate taxes since 2025.
A new publication or filing at ONCOLOGIX? We notify you, reason included.
Follow ONCOLOGIXDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind ONCOLOGIX is Everardo Delforge Saad.
Directors
According to the 2025 annual accounts
Everardo Delforge Saad
Director
Establishments
Establishment units
Physical locations of this company
Alphonse De Wittestraat 50 box 1
1050 Elsene
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 1027.890.093
- VAT number
- BE 1027.890.093
- Registered office
- Alphonse De Wittestraat 50 bus 1, 1050 Elsene
- Names & denominations
- ONCOLOGIX
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 19 September 2025
- Peppol
- Active · Active since 24 Oct 2025
- Activities · NACE
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied
Beroepsopleiding
Overige activiteiten van uitgeverijen, met uitzondering van het uitgeven van software
Organisatie van congressen en beurzen